Labshake search
Citations for Invivogen :
401 - 450 of 1365 citations for 1 3 Bis 2 4 hydroxyphenyl 2 propyl benzene since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2020Quote: ... 4 μg/μL Zeocin (Invivogen) were added to culture media ...
-
bioRxiv - Immunology 2022Quote: ... immunization with 50 µg TNP-KLH prepared with 1/3 volume of either alum or aluminum hydroxide gel (alhydrogel, Invivogen); 20 µg recombinantly produced trimer-stabilized HA (see below ...
-
bioRxiv - Immunology 2024Quote: Immune responses were induced in 6-12-week-old male and female mice by subcutaneous immunization in the right FP with 5 µg (for HA experiments) or 10 µg (for hapten-carrier experiments) supplemented with 1/3 volume alhydrogel adjuvant (Invivogen). In S1pr2-Tomato mice ...
-
bioRxiv - Genomics 2022Quote: ... the tissue was longitudinally cut and subjected to incubation in 3 mM EDTA in ice cold PBS with 1% (v/v) Primocin™ (InvivoGen, San Diego, CA; ant-pm-1) for 15 min at 4°C ...
-
bioRxiv - Immunology 2022Quote: ... 3 μg/mL puromycin (Invivogen, CA, USA) and 0.1 mg/mL Normocin (Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... a toll-like receptor 3 agonist (InvivoGen). Peptide doses of 50 ...
-
bioRxiv - Cell Biology 2022Quote: ... Selection with Puromicin (3 μg/ml; InvivoGen) started 72 h post infection ...
-
bioRxiv - Pathology 2020Quote: HEK-Blue™ Null1-v and HEK-Blue™-TLR4 (stably expressing TLR4, MD-2 and CD14 co-receptor genes) cell lines were obtained from Invivogen (SanDiego, CA, USA). HEK-Blue™ SR-AI and HEK-Blue™ CD36 were prepared by stably transfecting the parental cell line HEK-Blue™ Null1-v with plasmid pCMV/Hygro-SR-AI or pCMV/Hygro-CD36 (Sino Biological Inc. ...
-
bioRxiv - Immunology 2023Quote: ... Culture supernatants from THP-1 Dual cells (20 µl) were mixed with QUANTI-Luc 4 Lucia/Gaussia reagent (Invivogen), and luminescence was measured by a luminometer ...
-
bioRxiv - Immunology 2023Quote: ... 3 hours before infection Pam3CSK4 (Invivogen, tlrl-pms) was spiked into the wells at a final of 100 ng/mL ...
-
bioRxiv - Immunology 2024Quote: ... and 3 μg/mL puromycin (InvivoGen, ant-pr), and 100 μg/mL normocin (InvivoGen ...
-
bioRxiv - Immunology 2020Quote: ... with penicillin-streptomycin (100 units/mL) and activated using 3 µM CpG (ODN 7909) (tlrl-2006-1, Invivogen, San Diego, CA, USA). Cells were cultured in 200 µl medium for 1-8 days using round bottom 96-well plates ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... Omicron Variant (B.1.1.529/BA.1) pLV-SpikeV11) and Omicron Variants (BA.4/BA.5) pLV-SpikeV13) were purchased from InvivoGen (San Diego, CA). The human T-Cell lymphoma Jurkat (E6-1 ...
-
bioRxiv - Genomics 2022Quote: ... the tissue was longitudinally cut and subjected to incubation in 3 mM EDTA in ice cold PBS with 1% (v/v) primocin (InvivoGen, San Diego, CA) for 15 min at 4°C ...
-
bioRxiv - Pathology 2020Quote: ... a truncated HSP27 peptide consisting of the C-terminal half of the peptide, (100 µg, 75 µL) mixed with an aluminum hydroxide gel adjuvant (Alhydrogel® 2%, Al, 25 µL; Invivogen vac-alu-250, San Diego, CA). One week after the commencement of E2 and/or vaccinations ...
-
bioRxiv - Immunology 2022Quote: ... Omicron BA.1 or Omicron BA.2 Spike expression vectors lacking the 19 C-terminal amino acids containing the ER-retention signal (InvivoGen plv-spike-v11 and plv-spike-v12). HEK293T cells (1.2×106 cells ...
-
bioRxiv - Immunology 2020Quote: ... for 3 days with 0.5 μg/mL LPS (Invivogen) and 0.5 μg/mL anti-IgM F(ab’)2 (Jackson ImmunoResearch) ...
-
bioRxiv - Bioengineering 2022Quote: ... (3) LPS and 150 μg/ml Polymyxin B (Invivogen) for 45 and 90 min ...
-
bioRxiv - Immunology 2022Quote: ... which were selected by blasticidin (3 μg/ml, InvivoGen) for 4 days prior to the experiments.
-
bioRxiv - Cell Biology 2024Quote: ... Pam-3-CSK4 (500 ng/mL, InvivoGen; tlrl-pms), PolyI:C (10 mg/mL ...
-
bioRxiv - Immunology 2021Quote: ... 4 µg cGAMP (Invivogen, San Diego, Californien, USA), 4 µg c-di-UMP (Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... for 4 hours and 10 μM nigericin (InvivoGen) for an additional 1 hour ...
-
bioRxiv - Immunology 2023Quote: ... and assayed with QUANTI-Luc 4 reagent (Invivogen). Luminescence was read immediately with an Envision system.
-
bioRxiv - Immunology 2023Quote: ... selective medium containing Puromycin (4 μg/ml, InvivoGen) was added and after 7 days cells were sorted using FACS Aria (BD ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were exposed to puromycin (3 μM final concentration, Invivogen) for 5 minutes or left untreated for control conditions ...
-
bioRxiv - Cell Biology 2024Quote: ... Transduced organoids were selected using 3 μg/ml blasticidin (InvivoGen) and maintained as polyclonal populations.
-
bioRxiv - Developmental Biology 2024Quote: ... The chemical inhibitor or DMSO solution was replaced with fresh solution in the morning of 4 dpf and 5 dpf. Caspase-1 inhibitor - InvitroFit™ Ac-YVAD-cmk (Garcia-Calvo et al. 1998) (InvivoGen inh-yvad) was dissolved in DMSO and used at 20µM final working concentration ...
-
bioRxiv - Molecular Biology 2021Quote: ... Calu-3 (ACE2) cells further received 0.5 μg/ml puromycin (Invivogen). A549-ACE2 (Hoffmann et al. ...
-
bioRxiv - Immunology 2021Quote: ... was mixed with an Al (OH)3 adjuvant (Alhydrogel®, InvivoGen, France) and used as a candidate vaccine against SARS-CoV-2 ...
-
bioRxiv - Cell Biology 2020Quote: ... Stable transformants were selected using 4 μg/mL Blasticidin (Invivogen) and individual colonies were picked ...
-
bioRxiv - Immunology 2021Quote: ... 4 µg c-di-UMP (Invivogen, San Diego, Californien, USA) or mock-electroporated using a Gene Pulser Xcell Electroporation instrument (Bio-Rad Laboratories ...
-
bioRxiv - Immunology 2021Quote: HEK-Blue™ IL-4/IL-13 cells (InvivoGen, France) were cultured according to manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2021Quote: ... Cells were treated with 3 μg/ml plasmocin (Invivogen, San Diego, CA, USA) to prevent mycoplasma contamination ...
-
bioRxiv - Cancer Biology 2020Quote: ... Transduced cells were selected for 3 weeks using puromycin (5 μg/mL,-InvivoGen).
-
bioRxiv - Immunology 2023Quote: ... The Class B CpG ODN2006 (ODN 7909, PF_3512676, sequence: 5’-tcgtcgttttgtcgttttgtcgtt-3’, Invivogen) was diluted in sterile endotoxin-free water ...
-
bioRxiv - Immunology 2022Quote: ... and with 3 μg/ml TLR7 agonist imiquimod (InvivoGen, San Diego, CA, USA) for 3 days ...
-
bioRxiv - Cell Biology 2021Quote: ... infected cells were selected with medium containing 3 μg/ml puromycin medium (Invivogen, CA) for 4 days and resulting heterogenous pools were used for functional assays ...
-
bioRxiv - Immunology 2021Quote: ... and incubated for 3 hours in the presence of LPS (10 ng/ml, Invivogen). Primary monocytes were then treated for 1 h 30 with nigericin (5 μM ...
-
bioRxiv - Biophysics 2023Quote: ... MEFs stably expressing Skylan-NS–LC3B were selected with 3 µg/mL puromycin (Invivogen), seeded on a glass slide coated with 0.3 mg/ml collagen (Nitta Gelatin ...
-
bioRxiv - Biophysics 2023Quote: ... Cell culture media was supplemented with 3 µg/ml puromycin (InvivoGen, San Diego, USA). As a control ...
-
bioRxiv - Immunology 2023Quote: ... cells were transferred to selective medium containing 4 µg/mL Blasticidin (Invivogen) (MC38-B2m-/- transduced with Her2/neu ...
-
bioRxiv - Systems Biology 2023Quote: ... TLR4 agonist at 4 ng/mL (LPS-B5, Invivogen, San Diego, CA), BTC at 40 ng/mL (human recombinant Betacellulin protein ...
-
bioRxiv - Molecular Biology 2020Quote: ... Disease was induced between 6 and 10 weeks of age using 3 mg curdlan (InvivoGen) administered by intraperitoneal injection ...
-
bioRxiv - Immunology 2023Quote: ... The Class C CpG ODN_2395 sequence (5’-TCGTCGTTTTCGGCGCGCGCCG-3’) was obtained from Invivogen (#tlrl-2395). We used the crystal structure of mouse TLR9 extracellular domain (TLR9 ECD ...
-
bioRxiv - Immunology 2024Quote: ... BMDCs were pretreated for 3 hours with either TLR4 inhibitor TAK-242 (InvivoGen, #tlr-cli95) at three different concentrations (1.25 μM ...
-
bioRxiv - Cancer Biology 2024Quote: ... or 10 mg/kg anti-CTLA-4 (clone 9D9, cat. mctla4-mab10, InvivoGen). Antibodies were administered twice weekly for a maximum of four weeks.
-
bioRxiv - Microbiology 2024Quote: ... Caspase-4 (cells were transfected with ultra-pure LPS (5 μg/ml, InvivoGen) for 6 hrs ...
-
bioRxiv - Immunology 2023Quote: ... and absorbance levels detected at 655 nm after 3 h incubation with QUANTI-Blue Solution (Invivogen). The absorbances of RAW-Blue assay were normalized to absorbance intensity at the highest and lowest dilutions ...
-
bioRxiv - Bioengineering 2024Quote: ... Antigens were injected intramuscularly at a dose of 3 μg and 5 μg with AddaVax (InvivoGen) in 100 μL for prime and boost ...
-
bioRxiv - Immunology 2020Quote: ... the cells were primed for 4 h with 500 ng/mL ultrapure LPS (InvivoGen). The supernatant was discharged and macrophages were infected with trypomastigote forms of T ...